![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 11, 2020 12:30:49 PM
FDA expands clearance for OTC pain device
FDA has granted a new marketing clearance for an OTC electromagnetic neuromodulation device for treating pain (ActiPatch—BioElectronics Corp). The device, which was previously cleared to treat knee osteoarthritis and plantar fasciitis in 2017, is now cleared for adjunctive treatment of any musculoskeletal pain.
FDA has granted a new marketing clearance for an OTC electromagnetic neuromodulation device for treating pain (ActiPatch—BioElectronics Corp). The device, which was previously cleared to treat knee osteoarthritis and plantar fasciitis in 2017, is now cleared for adjunctive treatment of any musculoskeletal pain. BioElectronics plans to capitalize on the new 510(k) clearance by offering additional products to retail channel partners, noting that its device is the only pulsed shortwave therapy with this type of clearance and indication. Results from a long-term prospective study of the device were published last year in Pain Research and Management. The study included 240 participants with chronic pain and found that 97% of the patients sustained a 60% reduction in pain at 6 months. One pain management specialist noted at the time that although there appeared to possibly be some clinically significant effects, more research should be conducted.
https://www.pharmacist.com/article/fda-expands-clearance-otc-pain-device
******************************************************************
The American Pharmacists Association is the largest association of pharmacists in the United States and is the only organization advancing the entire pharmacy profession. Our expert staff, and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists and pharmacy technicians find success and satisfaction in their work, while advocating for changes that benefit them and their patients.
From our headquarters in Washington, D.C., APhA prepares members to thrive at every career stage and in every pharmacy setting with world-class continuing education, transformative events, unique practice tools, and timely solutions to complex challenges. We’re committed to helping them deliver outstanding patient care, receive due recognition, and work at a full scope of practice. Pharmacists play a critical role in helping patients overcome illness and live healthier lives through chronic disease management and the fully effective use of their medicines. APhA advocates at the national level to give pharmacists a voice in decisions that affect their future while promoting their undeniable value to health care teams. Our goal is to facilitate pharmacists’ delivery of the highest quality patient-centered care.
Vision
The American Pharmacists Association inspires, innovates and creates opportunities for members and pharmacists worldwide to optimize medication use and health for all.
Mission
As the voice of pharmacy, the American Pharmacists Association leads the profession and equips members for their role as the medication expert in team-based, patient-centered care. APhA will accomplish this by:
Advancing pharmacists' optimal roles in team-based, patient-centered care.
Providing opportunities for professional development, recognition, differentiation, and leadership.
Disseminating timely relevant information and state-of-the-art tools and resources.
Raising societal awareness about the role of pharmacists as essential in patient care for optimal medication use.
Creating unique opportunities for members to connect and share with peers across practice settings.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM